Chris Kryder, M.D.
ckryder @ foundmed.com
Dr. Chris Kryder is a proven leader in today’s healthcare
information technology arena. Chris has served as chairman of Valence Health
since 2012. Previously, he founded and grew D2Hawkeye, selling the company to
ISO, which merged its health care Information technology assets to form Verisk
Health. He continued to lead the company after it went public as Verisk
Analytics (NASDAQ:VRSK). He also co-founded Generation Health, the first
Genetic-testing Benefits Manager (GBM), which was later sold to CVS Caremark.
Chris earned his B.A. from the University of Buffalo, his M.D. from Georgetown
University, and his MBA from the Massachusetts Institute of Technology. He
completed his internal medicine (primary care) medical residency at Harvard, and
maintained his primary care medical practice at MIT until the late 1990s. He has
been active on the faculty of Harvard Medical School, Division of Health,
Science, and Technology for more than 25years.